Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.38 - $6.48 $2.26 Million - $3.34 Million
514,851 Added 12.71%
4,566,251 $22.8 Million
Q1 2024

May 13, 2024

BUY
$3.54 - $6.84 $3.7 Million - $7.14 Million
1,044,000 Added 34.71%
4,051,400 $25 Million
Q4 2023

Feb 09, 2024

BUY
$4.16 - $6.87 $4.19 Million - $6.92 Million
1,007,400 Added 50.37%
3,007,400 $15.2 Million
Q3 2023

Nov 13, 2023

SELL
$3.56 - $5.75 $3.1 Million - $5.01 Million
-870,523 Reduced 30.33%
2,000,000 $11.5 Million
Q2 2023

Aug 11, 2023

SELL
$3.51 - $4.69 $454,464 - $607,247
-129,477 Reduced 4.32%
2,870,523 $10.4 Million
Q2 2022

Aug 11, 2022

BUY
$1.23 - $3.25 $2.46 Million - $6.5 Million
2,000,000 Added 200.0%
3,000,000 $9.75 Million
Q3 2021

Nov 12, 2021

BUY
$4.89 - $7.12 $4.89 Million - $7.12 Million
1,000,000 New
1,000,000 $4.9 Million
Q2 2019

Aug 09, 2019

SELL
$22.93 - $42.84 $5.73 Million - $10.7 Million
-250,000 Closed
0 $0
Q1 2019

May 10, 2019

BUY
$32.69 - $47.91 $8.17 Million - $12 Million
250,000 New
250,000 $9.71 Million
Q3 2018

Nov 09, 2018

SELL
$36.35 - $55.2 $3.64 Million - $5.52 Million
-100,000 Closed
0 $0
Q2 2018

Aug 10, 2018

SELL
$33.85 - $50.65 $1.69 Million - $2.53 Million
-50,000 Reduced 33.33%
100,000 $3.83 Million
Q1 2018

May 10, 2018

BUY
$32.45 - $54.7 $1.88 Million - $3.17 Million
57,922 Added 62.91%
150,000 $6.02 Million
Q4 2017

Feb 09, 2018

BUY
$21.8 - $39.35 $2.01 Million - $3.62 Million
92,078
92,078 $3.23 Million

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.24B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Artal Group S.A. Portfolio

Follow Artal Group S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

News

Stay updated on Artal Group S.A. with notifications on news.